Open access peer-reviewed chapter - ONLINE FIRST

Mouse Models to Understand Mutagenic Outcomes and Illegitimate Repair of DNA Damage

Written By

Kiran Lalwani, Caroline French and Christine Richardson

Submitted: January 1st, 2022 Reviewed: February 25th, 2022 Published: April 17th, 2022

DOI: 10.5772/intechopen.103929

Mutagenesis and Mitochondrial-Associated Pathologies Edited by Michael Fasullo

From the Edited Volume

Mutagenesis and Mitochondrial-Associated Pathologies [Working Title]

Dr. Michael Thomas Fasullo and Prof. Angel Catala

Chapter metrics overview

14 Chapter Downloads

View Full Metrics


Maintenance of genome integrity is critical to prevent cell death or disease. Illegitimate repair of chromosomal DNA breaks can lead to mutations and genome rearrangements which are a well-known hallmark of multiple cancers and disorders. Endogenous causes of DNA double-strand breaks (DSBs) include reactive oxygen species (ROS) and replication errors while exogenous causes of DNA breaks include ionizing radiation, UV radiation, alkylating agents, and inhibitors of topoisomerase II (Top2). Recent evidence suggests that a growing list of environmental agents or toxins and natural dietary compounds also cause DNA breaks. Understanding the consequences of exposure to a broad spectrum of DSB-inducing agents has significant implications for understanding mutagenicity, genome stability and human health. This chapter will review in vivo mouse models designed to measure DNA damage and mutagenicity, and illegitimate repair of DNA DSBs caused by exposure to environmental agents.


  • mutagenicity
  • double-strand breaks
  • illegitimate repair
  • genome rearrangement
  • transgenic mouse model
  • genome instability

1. Introduction

The faithful repair of DNA lesions is central to the maintenance of genomic integrity [1]. Illegitimate repair of chromosomal DNA breaks can lead to mutations and genome rearrangements which are a well-known hallmark of multiple cancers, aging, and disease [2, 3]. DSBs can occur in a programmed manner during a metabolic process such as DNA replication, during meiosis, and the development of the immune system during V(D)J recombination and immunoglobulin class switch recombination [4] or endogenous agents such as ROS and replication errors [5]. DSBs also occur as a result of exposure to exogenous agents such as ionizing radiation, UV radiation, alkylating agents, topoisomerase inhibitors, and chemotherapeutic drugs [6, 7, 8]. Evidence shows that a growing list of natural compounds in the human diet or the environment also causes DNA breaks [9].

Mammalian cells have evolved sophisticated mechanisms to detect the damage via the DNA damage response (DDR) and signaling pathway which then activates repair pathways to maintain genome integrity [10]. Major mammalian processes to detect and repair DNA DSBs include homologous recombination (HR) and non-homologous end joining (NHEJ) (Figure 1). Both of these repair pathways are cell cycle-specific and differ based on their requirement for a donor DNA template with significant DNA sequence similarity. Studies suggest NHEJ is most prevalent in non-cycling somatic cells during the G1 stage, while HR is particularly active during the S, G2, and M stages due to its requirement for a homologous sequence as a donor template [11, 12]. In NHEJ the broken ends are processed and ligated together without requiring homology. By contrast, HR uses an undamaged homologous sequence from a sister chromatid, allelic locus, or an ectopically located sequence from a heterologous chromosome as a template to initiate HR or break-induced replication repair at the broken site [13].

Figure 1.

The DNA double-strand breaks (DSB) are repaired by the two pathways; These are—(A) non-homologous end joining (C-NHEJ) which modifies the ends and allows ligation of the broken ends to repair the DSB; (B) homologous recombination (HR) that uses a homologous sequence from sister chromatid or homologous chromosome or a homologous sequence within the genome.

Laboratory mice (Mus musculus) have been key to most in vivostudies on DNA damage and mutagenicity or illegitimate repair that take into account the complex environment of the mammalian system including tissue architecture, cellular differentiation programs, chromatin landscape patterns, and aging [14, 15, 16, 17, 18]. Multiple in vivomodels have been developed to examine the potential for the repair of DNA DSBs [19, 20]. Furthermore, specific cell types within tissues and organs encounter a diverse set of DNA damaging insults that produce distinct types of DNA damage. Individual cells differ in their capacity for sensing, responding, and repairing specific DNA lesions [17].


2. Induction and assessment of mutagenicity by endogenous sources

2.1 Programmed DNA DSBs

Endogenous DNA DSBs can occur as deliberate, cell-required mechanisms. DNA DSBs drive the non-sister chromatid HR events responsible for genetic diversity in meiotic cells [21]. These events can lead to rearrangements including deletions, tandem duplications, inversions, and translocation of chromosomes which are not always favorable for the cell [22]. Analogous to topoisomerase II (Top2), the Spo11 enzyme initiates DSBs during prophase I of meiosis. The locations Spo11-mediated DSBs are not random and are referred to as DNA hotspots expected to occur somewhere between 10,000 and 40,000 times within the mammalian genome [23]. These DSBs initiate meiotic HR via gene conversion and crossover events. Spo11−/− knockout mice have errors in normal meiotic chromosome synapsis formation [24]. PRDM9 methyltransferase and its associated binding specificity determine the DSB hotspot locations in mice by generating nucleosome-depleted regions, allowing for the programmed DSBs to occur via Spo11 cleavage [25].

2.2 Reactive oxygen species and replication stress

DNA DSBs can occur due to the accumulation of ROS-induced oxidative stress or as the result of replication or transcription stress. ROS are often linked to neurological diseases and cancer, although they result from endogenous cellular metabolism. Some examples of endogenous ROS include the superoxide radical anion (O2˙), hydroxyl radical (OH˙), peroxynitrite (ONOO), and hypochlorous acid (HOCl) [26]. ROS cause DNA damage through their ability to alter the overall reduction-oxidation (redox) cell conditions to cause oxidative stress. By changing redox conditions of the cell, important cellular processes including signal transduction and proliferation may not be able to occur. The failure of these processes can be lethal for the cell or promote mutagenesis through GC to TA changes [27]. Guanine lesions that lead to a miscoding error change the structural integrity of the DNA by weakening hydrogen bonding between bases [26]. These guanine mutations are associated with ROS-related oxidative stress and can promote cancer development [27]. 8-Oxo-7,8-dihydroguanine (8-oxoG) is a common output of guanine oxidation. It is an important compound because of its susceptibility to further oxidation and overall genotoxicity [28].

The base excision repair (BER) pathway is a mechanism deployed to resolve DNA lesions, as the presence of 8-oxoG, and has three major steps: (1) recognition of the lesion by DNA glycosylases, (2) base excision, (3) resynthesis and replacement of the removed base [29]. DNA glycosylases initiate BER through cleaving the N-glycosidic bond between the damaged base and sugar. DNA glycosylases can be either monofunctional or bi-functional whereas bi-functional DNA glycosylases include a β-elimination or β, δ-elimination step after N-glycosidic bond cleavage [30]. Defects in the BER pathway’s mechanism can lead to the accumulation of BER intermediates, unrepaired lesions, point mutations, and DNA DSBs. DNA polymerase β(Pol β) is one of the most active DNA polymerases involved in BER. A single nucleotide polymorphism (SNP) on the gene coding for Pol βresults in proline residue 242 becoming arginine (P242R). This mutation is suggested to cause chromosomal aberrations, and therefore, genome instability. P242R was associated with an increase in SSBs and DSBs compared to wild-type cells, and cellular transformation in mouse and human cells. An observed increase in cellular proliferation with the expression of the P242R suggested this mutation may induce a carcinogenic phenotype [31].

Replication stress is any event causing changes to the replication rate and can include halting replication. Unrepaired DNA lesions contribute to replication stress by acting as a physical block of the replication fork and its motion [32]. Single strand breaks (SSBs) generated by replication stress can further generate DSBs by nucleases, deamination, or spontaneous hydrolysis [22]. These DSBs, as well as meiotic-related DSBs, will use NHEJ or HR for repair. Errors in HR, which are less common than in NHEJ, can lead to mutagenesis and overall genome instability [33]. Phosphorylation of target proteins by ATM also triggers DDR. Chk2 has protein kinase activity allowing it to phosphorylate several effector proteins in the cell cycle checkpoint including p53 which can be modified by either ATM or Chk2 (or ATR or Chk1). ARF protein (p14) seems to stabilize TIP60 interactions with ATM for better activation and is associated with maintaining genome stability [2].

2.3 Spontaneous DNA breaks

A reporter fluorescent yellow direct repeat (FYDR) mouse model was developed to assess DSB-induced intra-chromosomal recombination events in multiple tissues including skin [34, 35]. In this model, spontaneous DSBs or DSBs induced by replication fork collapse can lead to unequal sister chromatid exchange between tandem truncated enhanced yellow fluorescent protein (EYFP) sequences resulting in gene conversion and expression of EYFP quantifiable by flow cytometry. This model showed the in vivofrequency of spontaneous intra-chromosomal HR in multiple tissues calculated at approximately 10−5 to 10−6 per base pair per cell division. A modification of the model using a direct repeat-GFP (RaDR-GFP) inserted in the Rosa26locus contains two truncated EGFP sequences in tandem [14, 34, 35, 36]. This model detected spontaneous and DNA damage agent-induced intra-chromosomal HR in most gastrointestinal organs and respiratory organs. Cell-type-specific immunohistochemistry staining of the lung [36] and pancreata [35] demonstrated cell-type and tissue-type specificity of intra-chromosomal HR recombinant populations. This model also demonstrated that older mice show an order of magnitude increase in the accumulation of recombinant cells.


3. Induction and assessment of mutagenicity by exogenous agents

Exposure of mice to nonspecific agents such as IR, Top2 inhibitors and chemotherapeutic drugs induce DSBs more broadly across the genome and in physiologically relevant contexts (Figure 2).

Figure 2.

Exogenous exposure DNA double strand break induction, damage response pathway and repair. (A) The schematic figure shows induction of DNA damage via chemotherapeutics, radiation and environmental compounds. (B) The preliminary assessment of the DSB can be done by techniques such as comet assay, pulse electrophoresis and micronuclei staining. (C) Detection DNA damage response proteins such gamma H2AX, 53BP1 and BRCA1 foci using immunofluorescence staining. (D) Hr specific techniques such as SMART assay and brdu staining. (E) To determine repair frequencies several reporters are developed. For example, GFP recombinant cells shown in bottom right.

3.1 Ionizing and non-ionizing radiation

Ionizing radiations such as X-rays and gamma rays can cause direct damage by depositing energy or indirect damage by ionization of water molecules to produce free radicals that influence SSBs or DSBs [37, 38, 39, 40]. The complexities of the damage vary according to the linear energy transfer of the radiation [37]. Alpha particles are high LET radiation and directly cause breaks [41] while non-ionizing radiations such as UVA and UVB create indirect DSBs and SSBs [7]. Several DSB repair pathway-specific proteins have been examined on bases of the IR sensitivity such as MRE1 resection protein [42], BRCA1 [43], Ku 70 [44], and Pol θ [45, 46, 47]. Exposure of mice to irradiation can cause a variety of DNA lesions including base damage, SSBs and DSBs. However, DSBs have been deduced to be amongst the toxic lesions and contribute to cell death [37]. Erroneous repair of the DSBs causes chromosomal aberrations and influences carcinogenesis [38].

The earliest methods for detection of DSBs induced by irradiation included physical separation of the broken DNA from undamaged DNA by pulse-field gel electrophoresis and comet assays [47, 48]. However, these methods were not efficient for mouse studies because of their low reproducibility and limited approximation of DSB levels [50]. More recently, micronuclei scoring is more commonly used as these cytogenetic biomarkers are easily detectable through microscopy. Micronuclei are cytoplasmic chromatin masses resulting from damaging agents such as IR [49, 50]. Another prominent and widely used method for the detection of DSBs include the identification of DSB downstream biomarkers such as γH2AX that binds to DNA at sites flanking DSBs [51, 52]. This protein is a variant of H2AX histone and forms a focus at the sites of DSBs which further signals DDR and repair response [50, 51]. The γH2AX foci can be analyzed by immunohistochemical staining and visualization under fluorescent or confocal microscopy.

To determine the repair pathway choice of DSB repair association of DSBs with proteins specific for one pathway or another is typically employed. For example, HR requires resection of the broken DNA ends from ssDNAs that are recognized and covered by replication protein A (RPA) which can be detected through immunofluorescence. To monitor the length and speed of resection per DNA molecule, BrdU antibody is used which binds to the ssDNA and forms fibers visible under a fluorescent microscope. To increase the resolution of DNA fibers, Single-Molecule Analysis of Resection Tracks (SMART) can be used [53, 54].

3.2 Radiomimetic drugs

Commonly used chemotherapeutic drugs are categorized into 5 different types based upon their chemical composition and mode of action. Widely used anti-cancer drugs for DNA damage include alkylating agents such as temozolomide (TMZ) melphalan, and cyclophosphamide [55, 56]. These agents act by attaching the alkyl groups onto the DNA and interfering with the cell cycle and transcription process. They can also cross-link two double-strand DNA molecules creating inter-strand cross-links (ICLs). ICLs are dangerous lesions if not repaired. Alkylating agents can also add mismatched nucleotides which can cause genome instability [56]. Studies targeting DDR and DSB repair proteins that can alter the sensitivity of chemotherapeutic drugs are used for cancer treatment modalities. Recent research proposed that deficiency of the NHEJ protein DNA ligase4 significantly enhanced the sensitivity of cells to TMZ [57]. Mouse embryonic fibroblasts (MEFs) of DNA ligase 4 knockout mice treated with a D50 dose of TMZ have higher numbers γH2AX foci and significantly reduced cell survival when compared to wild-type suggesting that Ligase4 protects the cells against lesions from TMZ [57].

ICL-inducing agents, such as mitomycin C (MMC), nitrogen mustards, and platinum can create cross-links that hinder DNA replication, thus preferentially targeting highly proliferative cells. Thus, these agents are widely used in the treatment of cancers and several skin conditions [55, 58]. The repair of ICLs involves both translesion break repair and HR proteins, and mutation of HR genes leads to sensitivity to ICL agents [59, 60]. Brca1 mutant mice ear fibroblasts and MEFs treated with MMC showed significantly reduced HR frequency and increased sensitivity to MMC. Interestingly, ATM mutant mice did not have a significant change in HR frequency even with higher MMC doses suggesting that ATM is dispensable for HR [59].

Molecular studies indicate the necessity of Top2 in the maintenance of genome integrity. The ability to halt Top2 function and generate enzyme-mediated DNA damage is a key reason why it is used in secondary cancer chemotherapy such as therapy-related acute myeloid leukemia (t-AML) [61, 62]. Top2 enzyme acts by catalyzing the interconversion of topological DNA isomers through the generation of a transient DSB on one DNA helix (“gate” strand) while remaining covalently linked to the 5′ end of the DNA, followed by passage of a second DNA helix (“transfer” strand) through the DSB, and then religation of the DSB [63]. Mammals have two isoforms of Top2—αand β [61]. Chemotherapeutic drugs doxorubicin and etoposide inhibit the catalytic activity of Top2 after generating the DSB resulting in high levels of trapped Top2:DNA complexes and unrepaired DSBs [9, 61]. Such agents are also referred to as Top2 “poisons” [61]. A novel insight into secondary malignancies induced by these Top2 targeting drugs has come from studies using a transgenic mouse model with a skin-specific ablation of Top2β [63]. These skin-specific top2β-knockout mice were exposed to etoposide to evaluate the role of the two isozymes of DNA, Top2α and Top2β. The results demonstrated that in the absence of Top2β, there was a reduction in NHEJ induced by etoposide, suggesting a potential role of NHEJ repair in promoting the malignancies created by improper repair of these lesions [64, 65].

3.3 Pollutants and environmental compounds

Chemical compounds including air and water pollutants, pesticides and some dietary compounds are genotoxic and linked to carcinogenesis. Air pollutants such as benzene and sulfur oxide are released by the combustion of fossil fuels are often linked with leukemias [65, 66]. An in vivostudy demonstrated how benzoquinone (BQ) environmental agent-induced recombination in fetal hematopoietic cells in pKZ1 transgenic mice [67]. BQ potentially induced ROS measured by a significant increase in the ROS product 8-OH-2′-dG. This was followed by DSB induction that was detected by a significant increase in γH2AX foci in the BQ treated cells. The widely used pesticide endosulfan is speculated to cause chromosomal abnormalities in humans [68, 69]. Adult wild-type BALB/c mice fed endosulfan and analyzed for DSBs and ROS-mediated damage showed an increase in γH2AX foci and a significant increase in the levels of the NHEJ-associated protein 53BP1 in lungs and testes. Furthermore, elevations of several other proteins involved in the alternative end joining (Alt-EJ) pathway were evaluated by Western blot. This study provided compelling insight on the mechanism of action of endosulfan pesticide [69].

Bisphenol A (BPA) is a hormonally active environmental xenoestrogen widely found in food products. It is an epigenetic toxicant that can alter the DNA by the generation of ROS [70]. Bioflavonoids are polyphenolic compounds found in various dietary products such as soy, coffee, fruits, and vegetables [71]. These compounds have been characterized to be mechanistically and biochemically similar to the Top2 inhibitor and chemotherapeutic drug etoposide [72, 73]. In addition, bioflavonoids have been shown to cross the placental barrier and can induce MLLbreakpoint cluster region cleavage suggesting an association with the initiation of infant leukemia [74]. A study reported prenatal exposure to flavonoids genistein or quercetin can increase the risk for leukemia onset, as assessed by the frequency of MLLtranslocations in an ATM mutant mouse model prone to develop cancer [75]. Prenatally exposed fetuses were examined at gestation day 14.5 by inverse-PCR to detect MLLtranslocations and their frequency in the fetal liver. Additionally, mice prenatally exposed to flavonoids genistein or quercetin were euthanized at 12-weeks and inverse PCR was performed to determine the presence of MLLtranslocations. These prenatally exposed mice developed leukemia albeit at later ages [75]. These results are further supported by an embryonic stem cell GFP-NHEJ model to identify chromosomal translocations between MLLand AF9breakpoint cluster regions analogous to those observed in infant leukemia [76]. Upon damage induced by etoposide or a large panel of flavonoids, DSBs in the two loci and repair by NHEJ produced a chromosomal translocation resulting in a functional full-length GFP at least partly dependent on Top2 [76, 77]. Another study examined epigenetic effects of genistein on hematopoiesis in mice; mice prenatally exposed to genistein showed the significant increase in erythropoiesis. Furthermore, transcriptional microarray analysis suggested that genistein exposure was associated with hypermethylation of certain repetitive elements which coincided with a significant down-regulation of genes involved in hematopoiesis in bone marrow cells and estrogen-responsive genes of genistein-exposed mice [78].

Another reporter system assesses mutagenic events through the Escherichia coli-derived LacZ gene, which codes for the production of β-galactosidase. β-Galactosidase cleaves lactose forming galactose and glucose, but is receptive to substrate 4-bromo-5-chloro-3-indolyl β-D-galactopyraniside (X-Gal) and produces blue precipitate when bound to β-galactosidase. The blue precipitate is observable through light microscopy [79]. Shuttle vectors carrying the bacterial reporter gene include micro-injection of bacteriophages and electroporation of plasmids for the development of transgenic mice for mutagenetic assay. Transgenic LacZ+ mice have been dosed with different mutagenic chemical compounds, like ethyl nitrosourea, chlorambucil, and benzo[α]pyrene, to observe changes in the production of X-Gal’s blue precipitate as an indicator of mutagenicity [80]. The Mutamouse and Big Blue transgenic mouse models were developed via bacteriophages. Mutamouse utilizes bacteriophage λDNA (λgt10) as a vector for LacZ insertion at an EcoRI restriction site. Excision of the LacZ gene for analysis and a positive agar selection system is used with scoring of the clear plaques to identify mutants. Big Blue also has a λbacteriophage shuttle vector for LacZ, but a non-selectable color screening assay to provide a ratio of blue plaques to white plaques and consequently a mutation frequency [81]. In the 35.5 transgenic mouse system, the LacZ transgene concameter is in a particularly unstable chromosomal region near the pseudo-autosomal region on the X-chromosome resulting in an increased potential for germinal and somatic mutations [80].


4. Induction and assessment of mutagenicity by site-directed cleavage

Nonspecific DNA damaging agents including chemotherapeutic drugs, environmental agents and radiation provide a global understanding of cell function during the response to DNA damage and DSBs. Molecular analysis of specific repair is difficult as spontaneously occurring DNA breaks occur in unknown locations. Off-target effects on the genome can be limited by using tools such as endonucleases and retroviruses. In addition to site-specific damage induced by specific endonucleases, a defective selectable marker or a defective fluorescent protein such as green fluorescent protein (GFP) can be added to develop a reporter system [82]. The endonuclease induces DSBs, and repair can result in a fluorescent or selectable active marker that was previously defective (Figure 3).

Figure 3.

Schematic of a GFP reporter system. This cassette consists of a ISceI-GFP is a modified GFP gene, which contains an 18 bp long ISceI recognition site and in-frame termination codons and a downstream a GFP donor fragment. Addition of an ISceI gene donor to this system induces DNA DSB at the ISceI site. Homologous recombination by gene conversion results in a functional GFP gene.

4.1 Recombinase cleavage and repair reporters

Development of conditional and inducible in vivoreporter assays allows for manipulation of gene expression, and molecular identification of deletion or addition of DNA sequence at specific loci. Generally, a DNA recombinase enzyme is involved in the development of conditional reporter systems. Recombinase enzymes such as Cre and FRT catalyze a concerted recombination reaction between two target sequences (loxP for Cre and FRT for FLP). Depending on the relative orientation of the target sites, catalysis results in the excision of the DNA gene sequences between the target sequences [83, 84]. A conditional Nbs1 null mouse MEF system developed with cre-lox recombinase provided insight regarding the role of the MRE11, RAD50 and NBS1 (MRN) complex with other repair proteins in DSB processing and HR. Nbs1 null MEFs treated with MMC or IR followed by Western blotting and immunohistochemistry of Brca1 and Rad51 indicated that loss of Nbs1 affected single-strand annealing via Rad51 suggesting its role in promoting HR. In support of this, PCR and Southern blotting suggested that loss of Nbs1 in an embryonic stem cell line promoted NHEJ repair [85].

4.2 Endonuclease cleavage and repair reporters

Restriction enzymes can induce site-specific DSBs with their sequence specificity to target DNA. Intron specific encoded endonuclease 1 (ISceI) derived from Saccharomyces cerevisiaeis one of the first endonucleases used for the study of HR in mammalian cells and, subsequently, in vivo[82, 86].

The G2S mouse model was developed to determine the potential for DSB-induced inter-chromosomal HR repair in vivo[84]. This G2S mouse model was genetically engineered to contain three distinct transgenes—two non-functional green fluorescent protein (GFP) reporter transgenes and a bi-cistronic doxycycline (Dox)-inducible ISceI transgene. Each GFP reporter construct contains an ISceI recognition site that renders it non-functional and provides for the induction of specific DSBs. Repair of the ISceI-induced DSBs by inter-chromosomal HR generates a functional GFP gene. While no GFP+ cells were detected without Dox (<1 × 10−8), following the addition of Dox to mouse chow or drinking water, fluorescent GFP+ cells were detected in a large spectrum of tissue types and hematopoietic progenitor cell populations visualized by fluorescent microscopy and quantitated by flow cytometry. Similar to results with RaDR mice and intra-chromosomal HR, aged G2S mice showed reduced numbers of inter-chromosomal HR cell populations [87].

Another study examined the genetic interactions between ATM, BRCA1, and 53BP1 in mice using a hypomorphic mutant, Brca1S1598F (Brca1SF) [88]. To study the role of these proteins in intra-chromosomal HR, primary fibroblasts from Brca1SF/SF mice and Atm−/− mice were integrated with a direct repeat GFP (DR-GFP) reporter and a Dox-inducible ISceI endonuclease. The DR-GFP contains a full-length nonfunctional GFP gene containing an ISceI endonuclease site followed by a downstream GFP homologous donor sequence; DSBs induced by ISceI cleavage can promote intrachromosomal HR repair to result in GFP+ cells. While spontaneous GFP+ cells were minimal (<0.01%), Dox addition to wild-type cells resulted in detection of GFP+ cells indicating HR repair (3–4%). Both Brca1SF and Atm−/− models showed a 3- and 2-fold reduction in GFP+ cells, respectively. ATM inhibition in wild-type cells only reduced HR by 1.6-fold, while ATM inhibitor exacerbated the generation of GFP+ cells in Brca1SF/SF fibroblasts as compared to wild-type and Atm−/− fibroblasts. PCR-based assay with the DR-GFP reporter was used to quantify the SSA pathway which suggested significant reduction. Interaction of Atm, Brca and 53 bp1 in HR, was demonstrated by the appearance of RAD51 foci from ear fibroblasts. Examination of triple mutants indicated the plausible role of ATM in generating end-resected intermediates for RAD51 filament formation in cells with compromised BRCA1 and 53BP [88].

A recent age-dependent study developed a knock-in R26BHEJ model to determine the efficiency of frequency of intrachromosomal NHEJ for repair. R26BNHEJ knock-in is a GFP-based NHEJ reporter inserted into the ROSA26A locus. The DSBs are created using ISceI and repair by NHEJ was analyzed in several tissues using flow cytometry. This model demonstrated that there was a 1.8 to 3.8-fold decline of NHEJ efficiency with increased age [89].

In the past two decades, new approaches of gene editing have enormously expanded mutagenesis studies. Use of artificial nuclease like zinc-finger (ZFN), transcription activator-like effector (TALEN) nuclease, and the latest clustered regularly interspaced short palindromic repeat (CRISPR)/associated (Cas9) system has enhanced precision of gene editing [90, 91]. ZFN and TALEN nucleases consist of sequence-specific DNA-binding domains that are fused to a nonspecific DNA cleavage module such as FokI endonuclease. These systems readily search for sequence homology and the endonuclease cleaves at the recognition site, removing the target gene. Several development studies use ZFN and TALEN for gene editing [90]. A powerful approach for gene alteration is the CRISPR-Cas9 system. This system was initially observed in bacteria as an immune response against viruses. It consists of a single-guide RNA (sgRNA), that targets a palindromic region in the specific location of the genome, which is recognized by Cas9 nuclease generating a DNA DSB that subsequently activates the cellular DNA repair machinery. HR or NHEJ repair would result in alteration of the target gene by indel mutations [92, 93].


5. Induction and assessment of mutagenicity in utero

In uterostudies can provide valuable insight into the physiological processes that make mammalian models unique. Although, the single-cell Saccharomyces cerevisiaehas a large number of genes with homologs in mammals that are involved in DNA damage, signaling and repair [94], it is important to consider the mouse model’s advantage to understanding DNA damage and repair in multiple organ systems that a single-cell model cannot provide. Oogenesis, embryogenesis, and spermatogenesis are processes that give valuable insight to mutagenicity because of their roles in development and meiotic recombination and their potential to lead to trans-generational mutational consequences.

5.1 Gametocyte-based assays

Understanding the mammalian recombination pathway is useful for developing mouse models that can be used to appropriately study meiotic recombination stress and DSB repair. Because knockout of MRN complex components causes embryonic lethality, conditional disruption of NBS1 has been utilized in germ cells to assess how the MRN complex is functioning during meiotic DSB repair in mice [95]. A germ cell-specific transgenic mouse model inactivates targeted gene expression utilizing Vasa-cre[95, 96]. In Nbs1flox/−;Vasa-Cre (Nbs1 vKO)transgenic mice, NSB1 was conditionally knocked out preceding the time in meiotic development when Spo11-mediates DSBs. In this system, male mice were infertile. Zhang et al.observed improper chromosome synapsis using SYCP3 and γH2AX immunostaining of spermatocytes. Immunostaining also showed nuclear localization of MRE11 in the spermatocytes was disrupted by the depleted NBS1. Development of the Nbs1 vKO transgenic mouse model allowed for the assay of NBS1 as an indicator of MRN function, and in turn, meiotic recombination stress [95].

5.2 Applications

As modern healthcare concerns center around fetal development, mouse models can be used to understand how meiotic recombination is affected by compounds in our environment. Oogenesis is particularly important because the events of meiotic prophase I are highly influential on fetal survival. An in uteromodel has been used to assess fetal exposure to supplemented estrogen and how meiotic prophase I progression is altered in response. 17-ß-estradiol (E2) was administered to pregnant mice. The meiotic outcomes were analyzed through γH2AX staining and examination by super-resolution structured illumination microscope where γH2AX presence would signify whether meiotic recombination occurred via the initiation of a DSB. Quantifying γH2AX in uterois a valuable tool for assessing meiotic mutagenicity and then later influences fetal development and success [97].

In uteroexposure to other environmental agents that cause DNA damage can be valuable for understanding carcinogenesis. The absence of the P53 tumor-suppressor gene is linked to spontaneous tumorigenesis [27, 98]. P53 knockout mice can be used as a model for assessing tumor development when exposed to cancer-causing agents. An in uterostudy evaluated the effects of high-dose vitamin E, hypothesized to have antioxidative properties, on tumorigenesis. Pregnant P53 knockout mice were fed high-dose vitamin E until gestation day 13 or gestation day 19. The addition of vitamin E altered the redox state of the in uteroenvironment. Furthermore, the oxidative stress on the ROS-dependent embryonic and fetal pathways was evaluated. DNA isolation was performed for the fetal and embryonic tissues and high-performance liquid chromatography was used to quantify the formation of 8-oxo-dG which would be used as an oxidation marker. Vitamin E dosing was associated with an increase in tumorigenesis in the p53 knockout mice; however, further studies are needed to explore the relationship between vitamin E and the tumorigenesis pathway [27]. Assessing vitamins sold commercially is valuable to improving our understanding of what supplements are safe during pregnancy and how ROS may influence in uterocancer development.

Oxidative stress has important connections to ovarian aging because these ROS lesions in ovarian follicles increase with age. Oocytes remain dormant in the diplotene stage until they are released for fertilization providing time for ROS-induced oxidative damage lesions to accumulate, and an increase of these lesions in ovarian follicles with age [99]. Pol βand BER, a pathway for repairing DNA lesions caused by ROS and oxidative damage, have been associated with the aging process. As rats age, Pol βlevels decline, and BER becomes less efficient [100]. Injection of small interfering RNA (siRNA) targeting Pol βinto young murine oocytes resulted in decreased numbers of normal oocytes, reduced oocyte survival, and an increase in detectable 8-oxoG levels, as compared to controls. In a complementary study, injection of Pol βcomplementary DNA (cDNA) into aged murine oocytes resulted in overexpression of Pol β, increased oocyte survival, and a decrease in detectable 8-oxoG levels, as compared to controls. These studies suggest that Pol βfunction is important for oocyte survival and aging. There is a potential to apply the overexpression of Pol βin clinical settings to improve oocyte survival and potentially slow the damaging effects of DNA lesions on aging oocytes. This is a potentially important finding for improving fertility and pregnancy outcomes as aging signs of progress [99].


6. Conclusion

Genomic instability plays a prominent role in the initiation of pathologies such as aging, immunodeficiencies and carcinogenesis. To combat the lethal effect of DNA damage and strand breaks, cells have evolved multiple, often overlapping DNA repair pathways efficiently and accurately repair DNA. Induction and assessment of genotoxicant DNA damage are particularly important in vivo. Further, these mouse models to assess DNA damage and repair can be combined with traditional mouse genetics to determine the impact of genetic modifications or polymorphisms with a focus on molecular analysis of DNA damage repair. As the number of designed and widely used synthetic environmental agents increases, understanding their impact on DNA integrity and downstream potential to promote mutagenicity is increasingly significant.



CR was funded in part by NIH/NIGMS and a Faculty Research Grant (UNC Charlotte). KL was funded in part by Proposal Development Summer Fellowship (UNC Charlotte).


Conflict of interest

The authors indicate no conflict of interest.


  1. 1. Lalwani K, Goodenow D, Richardson C. Eukaryotic Recombination: Initiation by Double-strand Breaks. In: Encyclopedia of Life Sciences. Hoboken, New Jersey: John Wiley & Sons, Ltd. 2020;1:69-76
  2. 2. Ciccia A, Elledge SJ. The DNA damage response: Making it safe to play with knives. Molecular Cell. 2010;40(2):179
  3. 3. Hoeijmakers JHJ. Molecular origins of cancer DNA damage, aging, and cancer. The New England Journal of Medicine. 2009;361:1475-1485
  4. 4. Jung D, Alt FW. Unraveling V(D)J recombination: Insights into gene regulation. Cell. 2004;116(2):299-311
  5. 5. Lindahl T, Barnes DE. Repair of endogenous DNA damage. Cold Spring Harbor Symposia on Quantitative Biology. 2000;65:127-133
  6. 6. Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA. Environmental and chemical carcinogenesis. Seminars in Cancer Biology. 2004;14(6):473-486
  7. 7. Limoli CL, Giedzinski E, Bonner WM, Cleaver JE. UV-induced replication arrest in the xeroderma pigmentosum variant leads to DNA double-strand breaks, -H2AX formation, and Mre11 relocalization. PNAS. 2002;99(1):233-238
  8. 8. Vítor AC, Huertas P, Legube G, de Almeida SF. Studying DNA double-strand break repair: An ever-growing toolbox. Frontiers in Molecular Biosciences. 2020;7:24
  9. 9. Goodenow D, Lalwani K, Richardson C. DNA damage and repair mechanisms triggered by exposure to bioflavonoids and natural compounds. In: DNA-Damages and Repair Mechanisms. London, UK: IntechOpen; 2021. DOI: 10.5772/intechopen.95453
  10. 10. Harper JW, Elledge SJ. The DNA damage response: Ten years after. Molecular Cell. 2007;28:739-745
  11. 11. Richardson C, Jasin M. Eukaryotic Recombination: Initiation by Double-strand Breaks. In: Encyclopedia of Life Sciences. Hoboken, New Jersey: John Wiley & Sons, Ltd. 2001;1. DOI: 10.1038/npg.els.0000577
  12. 12. Richardson C, Moynahan ME, Jasin M. Double-strand break repair by interchromosomal recombination: Suppression of chromosomal translocations. Genes & Development. 1998;12(24):3831-3842. DOI: 10.1101/gad.12.24.3831
  13. 13. Elliott B, Jasin M. Human genome and diseases: Review double-strand breaks and translocations in cancer. Cellular and Molecular Life Sciences. 2001;59:373-385
  14. 14. Wiktor-Brown DM, Hendricks CA, Olipitz W, Engelward BP. Age-dependent accumulation of recombinant cells in the mouse pancreas revealed by in situ fluorescence imaging. PNAS. 2006;103(32):11862-11867
  15. 15. Tratar UL, Horvat S, Cemazar M. Transgenic mouse models in cancer research. Frontiers in Oncology. 2018;8:268
  16. 16. White RR, Milholland B, de Bruin A, Curran S, Laberge RM, van Steeg H, et al. Controlled induction of DNA double-strand breaks in the mouse liver induces features of tissue ageing. Nature Communications. 2015;6(1):1-11
  17. 17. Simonatto M, Latella L, Puri PL. DNA damage and cellular differentiation: More questions than responses. Journal of Cellular Physiology. 2007;213:642-648
  18. 18. Pandita TK, Richardson C. Chromatin remodeling finds its place in the DNA double-strand break response. Nucleic Acids Research. 2009;37(5):1363-1377
  19. 19. Specks J, Nieto-Soler M, Lopez-Contreras AJ, Fernandez-Capetillo O. Modeling the study of DNA damage responses in mice. Methods in Molecular Biology (Clifton, N.J.). 2015;1267:413-437
  20. 20. Hakem R. DNA-damage repair; the good, the bad, and the ugly. EMBO Journal. 2008;27(4):589-605
  21. 21. Mehta A, Beach A, Haber J. Homology requirements and competition between gene conversion and break-induced replication during double-strand break repair. Molecular Cell. 2017;65:515-526
  22. 22. Tubbs A, Nussenzweig A. Endogenous DNA damage as a source of genomic instability in cancer. Cell. 2017;168(4):644-656
  23. 23. Coopera TJ, Garcia V, Neale MJ. Meiotic DSB patterning: A multifaceted process. Cell Cycle (Georgetown, Tex). 2016;15(1):13-21
  24. 24. Romanienko PJ, Daniel C-OR. The mouse Spo11 gene is required for meiotic chromosome synapsis. Molecular Cell. 2000;6:975987
  25. 25. Paiano J, Wu W, Yamada S, Sciascia N, Callen E, Paola Cotrim A, et al. ATM and PRDM9 regulate SPO11-bound recombination intermediates during meiosis. Nature Communications. 2020;11:1-15
  26. 26. Jena NR. DNA damage by reactive species: Mechanisms, mutation and repair. Journal of Biosciences. 2012;37(3):503-517
  27. 27. Chen CS, Wells PG. Enhanced tumorigenesis in p53 knockout mice exposed in utero to high-dose vitamin E. Carcinogenesis. 2006;27(7):1358-1368
  28. 28. Shafirovich V, Kropachev K, Anderson T, Liu Z, Kolbanovskiy M, Martin BD, et al. Base and nucleotide excision repair of oxidatively generated guanine lesions in DNA. Journal of Biological Chemistry. 2016;291(10):5309-5319
  29. 29. Marsden CG, Dragon JA, Wallace SS, Sweasy JB. Base excision repair variants in cancer. Methods in Enzymology. 2017;591:119-157
  30. 30. Talhaoui I, Matkarimov BT, Tchenio T, Zharkov DO, Saparbaev MK. Aberrant base excision repair pathway of oxidatively damaged DNA: Implications for degenerative diseases. Free Radical Biology and Medicine. 2017;107:266-277
  31. 31. Yamtich J, Nemec AA, Keh A, Sweasy JB. Germline polymorphism of DNA polymerase beta induces genomic instability and cellular transformation. PLoS Genetics. 2012;8(11):1003052
  32. 32. Zeman MK, Cimprich KA. Causes and consequences of replication stress. Nature Cell Biology. 2014;16(1):2
  33. 33. Guirouilh-Barbat J, Lambert S, Bertrand P, Lopez BS, Porro A, Chang M, et al. Is homologous recombination really an error-free process? Frontiers in Genetics. 2014;5:175
  34. 34. Wiktor-Brown DM, Olipitz W, Hendricks CA, Rugo RE, Engelward BP. Tissue-specific differences in the accumulation of sequence rearrangements with age. DNA Repair. 2008;7(5):694-703
  35. 35. Sukup-Jackson MR, Kiraly O, Kay JE, Na L, Rowland EA, Winther KE, et al. Rosa26-GFP direct repeat (RaDR-GFP) mice reveal tissue- and age-dependence of homologous recombination in mammals in vivo. PLoS Genetics. 2014;10(6):1-16
  36. 36. Kimoto T, Kay JE, Li N, Engelward BP. Recombinant cells in the lung increase with age via de novo recombination events and clonal expansion. Environmental and Molecular Mutagenesis. 2017;58(3):135
  37. 37. Li W, Li F, Huang Q , Shen J, Wolf F, He Y, et al. Quantitative, noninvasive imaging of radiation-induced DNA double-strand breaks in vivo. Cancer Research. 2011;71(12):4130-4137
  38. 38. Thompson LH. Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: The molecular choreography. Mutation Research—Reviews in Mutation Research. 2012;751(2):158-246
  39. 39. Vignard J, Mirey G, Salles B. Ionizing-radiation induced DNA double-strand breaks: A direct and indirect lighting up. Radiotherapy and Oncology. 2013;108(3):362-369
  40. 40. Little JB. Genomic instability and bystander effects: A historical perspective. Oncogene. 2003;22:6978-6987
  41. 41. Stanley FKT, Berger ND, Pearson DD, Danforth JM, Morrison H, Johnston JE, et al. A high-throughput alpha particle irradiation system for monitoring DNA damage repair, genome instability and screening in human cell and yeast model systems. Nucleic Acids Research. 2020;48(19):e111. DOI: 10.1093/nar/gkaa782
  42. 42. Buis J, Wu Y, Deng Y, Leddon J, Westfield G, Eckersdorff M, et al. Mre11 nuclease activity has essential roles in DNA repair and genomic stability distinct from ATM activation. Cell. 2008;135(1):85-96
  43. 43. Brodie SG, Xu X, Qiao W, Li W-M, Cao L, Deng C-X. Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice. Oncogene. 2001;20(51):7514-7523
  44. 44. Koike M, Yutoku Y, Koike A. The defect of Ku70 affects sensitivity to X-ray and radiation-induced caspase-dependent apoptosis in lung cells. Journal of Veterinary Medical Science. 2013;75(4):415-420
  45. 45. Goff JP, Shields DS, Seki M, Choi S, Epperly MW, Dixon T, et al. Lack of DNA polymerase θ (POLQ) radiosensitizes bone marrow stromal cells in vitro and increases reticulocyte micronuclei after total-body irradiation. Radiation Research. 2009;172(2):165-174
  46. 46. Scully R, Panday A, Elango R, Willis NA. DNA double-strand break repair-pathway choice in somatic mammalian cells. Nature Reviews Molecular Cell Biology. 2019;20:698-714
  47. 47. Langie SA, Azqueta A, Collins AR. The comet assay: Past, present, and future. Frontiers in Genetics. 2015;6:266. DOI: 10.3389/fgene.2015.00266
  48. 48. Kawashima Y, Yamaguchi N, Teshima R, Narahara H, Yamaoka Y, Anai H, et al. Detection of DNA double-strand breaks by pulsed-field gel electrophoresis. Genes to Cells. 2017;22(1):84-93
  49. 49. Hayashi M. The micronucleus test-most widely used in vivo genotoxicity test. Genes and Environment. 2016;38:18
  50. 50. Kinner A, Wu W, Staudt C, Iliakis G. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Research. 2008;36:5678-5694
  51. 51. Revet I, Feeney L, Bruguera S, Wilson W, Dong TK, Oh DH, et al. Functional relevance of the histone gammaH2Ax in the response to DNA damaging agents. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(21):8663-8667. DOI: 10.1073/pnas.1105866108
  52. 52. Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, et al. γH2AX and cancer. Nature Reviews Cancer. 2008;8:957-967
  53. 53. Cruz-García A, López-Saavedra A, Huertas P. BRCA1 accelerates CtIP-ediated DNA-end resection. Cell Reports. 2014;9(2):451-459
  54. 54. Huertas P, Cruz-García A. Single molecule analysis of resection tracks. Methods in Molecular Biology. Clifton, New Jersey: Humana Press Inc; 2018;1672:147-154
  55. 55. Wolf M, Eskerski H, Bauder-Wü St U, Haberkorn U, Eisenhut M. Alkylating benzamides with melanoma cytotoxicity: Experimental chemotherapy in a mouse melanoma model. Melanoma Research. 2006;16(6):487-496
  56. 56. Weber GF. DNA damaging drugs. Molecular Therapies of Cancer. 2014;12:9-112
  57. 57. Kondo N, Takahashi A, Mori E, Ohnishi K, McKinnon PJ, Sakaki T, et al. DNA ligase IV as a new molecular target for temozolomide. Biochemical and Biophysical Research Communications. 2009;387(4):656-660
  58. 58. Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, et al. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31:1869-1883
  59. 59. Kass EM, Helgadottir HR, Chen CC, Barbera M, Wang R, Westermark UK, et al. Double-strand break repair by homologous recombination in primary mouse somatic cells requires BRCA1 but not the ATM kinase. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(14):5564-5569
  60. 60. Hinz JM. Role of homologous recombination in DNA interstrand crosslink repair. Environmental and Molecular Mutagenesis. 2010;51:582-603
  61. 61. Nitiss JL, Nitiss KC. Tdp2: A means to fixing the ends. PLoS Genetics. 2013;9(3)
  62. 62. Nanya M, Sato M, Tanimoto K, Tozuka M, Mizutani S, Takagi M. Dysregulation of the DNA damage response and KMT2A rearrangement in fetal liver hematopoietic cells. PLoS One. 2015;10(12):1-18
  63. 63. Attia SM, Al-Anteet AA, Al-Rasheed NM, Alhaider AA, Al-Harbi MM. Protection of mouse bone marrow from etoposide-induced genomic damage by dexrazoxane. Cancer Chemotherapy and Pharmacology. 2009;64(4):837-845
  64. 64. Azarova AM, Lyu YL, Lin CP, Tsai YC, Lau JYN, Wang JC, et al. From the cover: Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(26):11014
  65. 65. Meng Z, Qin G, Zhang B. DNA damage in mice treated with sulfur dioxide by inhalation. Environmental and Molecular Mutagenesis. 2005;46(3):150-155
  66. 66. Philbrook NA, Winn LM. Benzoquinone toxicity is not prevented by sulforaphane in CD-1 mouse fetal liver cells. Journal of Applied Toxicology. 2016;36(8):1015-1024
  67. 67. Tung EWY, Philbrook NA, MacDonald KDD, Winn LM. DNA double-strand breaks and DNA recombination in benzene metabolite-induced genotoxicity. Toxicological Sciences. 2012;126(2):569-577
  68. 68. Fenner K, Canonica S, Wackett LP, Elsner M. Evaluating Pesticide Degradation in the Environment: Blind Spots and Emerging Opportunities. Science. 2013;341(6147):752-758
  69. 69. Sebastian R, Raghavan SC. Induction of DNA damage and erroneous repair can explain genomic instability caused by endosulfan. Carcinogenesis. 2016;37(10):929-940
  70. 70. Bariar B, Vestal CG, Richardson C. Long-term effects of chromatin remodeling and DNA damage in stem cells induced by environmental and dietary agents. Journal of Environmental Pathology, Toxicology and Oncology. 2013;32(4):307-327
  71. 71. Ross JA, Kasum CM. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annual Review of Nutrition. 2002;22:19-34
  72. 72. Skibola CF, Smith MT. Potential health impacts of excessive flavonoid intake. Free Radical Biology and Medicine. 2000;29(3-4):375-383
  73. 73. Spector LG, Xie Y, Robison LL, Heerema NA, Hilden JM, Lange B, et al. Maternal diet and infant leukemia: The DNA topoisomerase II inhibitor hypothesis: A report from the children’s oncology group. Cancer Epidemiology, Biomarkers & Prevention. 2005;14(3):651-655. DOI: 10.1158/1055-9965.EPI-04-0602
  74. 74. Schro¨der JP, Schro¨der-Van Der Elst S, van der Heide D, Rokos H, Morreale De Escobar G, Ko¨hrle AJ, et al. Synthetic flavonoids cross the placenta in the rat and are found in fetal brain. The American Journal of Physiology. 1998;274(2):E253-E256. DOI: 10.1152/ajpendo.1998.274.2.E253
  75. 75. Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(9):4790-4795. DOI: 10.1073/pnas.070061297
  76. 76. Bariar B, Vestal CG, Deem B, Goodenow D, Ughetta M, Engledove RW, et al. Bioflavonoids promote stable translocations between MLL-AF9 breakpoint cluster regions independent of normal chromosomal context: Model system to screen environmental risks. Environmental and Molecular Mutagenesis. 2019;60(2):154-167
  77. 77. Goodenow D, Emmanuel F, Berman C, Sahyouni M, Richardson C. Bioflavonoids cause DNA double-strand breaks and chromosomal translocations through topoisomerase II-dependent and -independent mechanisms. Mutation Research—Genetic Toxicology and Environmental Mutagenesis. 2020;849:503144
  78. 78. Vanhees K, Coort S, Ruijters EJB, Godschalk RWL, Schooten FJ, Doorn-Khosrovani SB van W. Epigenetics: Prenatal exposure to genistein leaves a permanent signature on the hematopoietic lineage. The FASEB Journal. 2011;25(2):797-807
  79. 79. Levitsky KL, Toledo-Aral JJ, López-Barneo J, Villadiego J. Direct confocal acquisition of fluorescence from X-gal staining on thick tissue sections. Scientific Reports. 2013;3:2937
  80. 80. Gossen J, de Leeuw W. LacZ transgenic mouse models: Their application in genetic toxicology. Mutation Research. 1994;307(2):451-459. DOI: 10.1016/0027-5107(94)90256-9
  81. 81. Dean SW, Brooks TM, Burlinson B, Mirsalis J, Myhr B, Recio L, et al. Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens. Mutagenesis. 1999;14(1):141-151. DOI: 10.1093/mutage/14.1.141
  82. 82. Richardson C, Jasin M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature. 2000;405:697-700
  83. 83. Huh WJ, Mysorekar IU, Mills JC. Inducible activation of Cre recombinase in adult mice causes gastric epithelial atrophy, metaplasia, and regenerative changes in the absence of "floxed" alleles. American Journal of Physiology. Gastrointestinal and Liver Physiology. 2010;299(2):G368-G380. DOI: 10.1152/ajpgi.00021.2010. Epub 2010 Apr 22
  84. 84. Matos-Rodrigues G, Martini E, Lopez BS. Mouse models for deciphering the impact of homologous recombination on tumorigenesis. Cancers. MDPI AG. 2021;13(9):2083
  85. 85. Yang YG, Saidi A, Frappart PO, Min W, Barrucand C, Dumon-Jones V, et al. Conditional deletion of Nbs1 in murine cells reveals its role in branching repair pathways of DNA double-strand breaks. EMBO Journal. 2006;25(23):5527-5538
  86. 86. Jasin M. Genetic manipulation of genomes with rare-cutting endonucleases. Trends in Genetics. 1996;12(6):224-228
  87. 87. White RR, Sung P, Vestal CG, Benedetto G, Cornelio N, Richardson C. Double-strand break repair by interchromosomal recombination: An in vivo repair mechanism utilized by multiple somatic tissues in mammals. PLoS One. 2013;8(12):1-16
  88. 88. Chen CC, Kass EM, Yen WF, Ludwig T, Moynahan ME, Chaudhuri J, et al. ATM loss leads to synthetic lethality in BRCA1 BRCT mutant mice associated with exacerbated defects in homology-directed repair. Proceedings of the National Academy of Sciences of the United States of America. 2017;114(29):7665-7670
  89. 89. Vaidya A, Mao Z, Tian X, Spencer B, Seluanov A, Gorbunova V. Knock-in reporter mice demonstrate that DNA repair by non-homologous end joining declines with age. PLoS Genetics. 2014;10(7):1-9
  90. 90. Sommer D, Peters AE, Baumgart AK, Beyer M. TALEN-mediated genome engineering to generate targeted mice. Chromosome Research. 2015;23(1):43-55
  91. 91. Meyer M, Hrabé De Angelis M, Wurst W, Kühn R. Gene targeting by homologous recombination in mouse zygotes mediated by zinc-finger nucleases. PNAS. 2010;107(34):15022-15026. DOI: 10.1073/pnas.1009424107
  92. 92. Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346(6213):1258096. DOI: 10.1126/science.1258096
  93. 93. Shin JJ, Schröder MS, Caiado F, Wyman SK, Bray NL, Bordi M, et al. Controlled cycling and quiescence enables efficient HDR in engraftment-enriched adult hematopoietic stem and progenitor cells. Cell Reports. 2020;32(9):108093
  94. 94. Botstein D, Chervitz SA, Cherry JM. Yeast as a model organism. Science (New York, N.Y.). 1997;277(5330):1259
  95. 95. Zhang B, Tang Z, Li L, Lu LY. NBS1 is required for SPO11-linked DNA double-strand break repair in male meiosis. Cell Death and Differentiation. 2020;27(7):2176-2190
  96. 96. Gallardo T, Shirley L, John GB, Castrillon DH. Generation of a germ cell-specific mouse transgenic Cre line. Vasa-Cre. Genesis. 2007;45(6):413-417
  97. 97. Mu X, Tu Z, Chen X, Hong Y, Geng Y, Zhang Y, et al. In utero exposure to excessive estrogen impairs homologous recombination and oogenesis via estrogen receptor 2 in mice. Frontiers in Cell and Developmental Biology. 2021;9:1352
  98. 98. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992;356(6366):215-221
  99. 99. Hua K, Wang L, Sun J, Zhou N, Zhang Y, Ji F, et al. Impairment of Pol β-related DNA base-excision repair leads to ovarian aging in mice. Aging (Albany NY). 2020;12(24):25207-25228
  100. 100. Krishna TH, Mahipal S, Sudhakar A, Sugimoto H, Kalluri R, Rao KS. Reduced DNA gap repair in aging rat neuronal extracts and its restoration by DNA polymerase b and DNA-ligase. Journal of Neurochemistry. 2005;92:818-823

Written By

Kiran Lalwani, Caroline French and Christine Richardson

Submitted: January 1st, 2022 Reviewed: February 25th, 2022 Published: April 17th, 2022